Poland· PL-100451456

Ramidilan HCT

A ramipril, amlodipin und hydrochlorothiazid product containing ramiprilum + amlodipinum + hydrochlorothiazidum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 2 of our 19 countries.

ATC C09BX03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRamidilan HCTATCC09BX03REGISTER NO.PL-100451456PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Ramipril, amlodipin und hydrochlorothiazid is registered in 2 of 19 countries.

Countries holding a registration under ATC C09BX03 (ramipril, amlodipin und hydrochlorothiazid), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Ramipril, amlodipin und hydrochlorothiazid · ATC C09BX03

2 / 19 countries

  • Italyprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ramiprilum + Amlodipinum + Hydrochlorothiazidum
Manufacturer
G.L. Pharma GmbH
Country
Poland (PL)
ATC code
C09BX03
ATC class
Ramipril, Amlodipin und Hydrochlorothiazid
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991510787
  • gtin
    05909991510794
  • gtin
    05909991510800
  • gtin
    05909991510817
  • gtin
    05909991510824

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ramipril, amlodipin und hydrochlorothiazid in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ramipril, amlodipin und hydrochlorothiazid products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Ramipril/Amlodipin/Hct 1a Pharma, Ramipril/Amlodipin/Hct Genericon
  • Bulgaria · Pамиприл/Амлодипин/Xидрохлоротиазид Адамед, Рамира Трио
  • Germany · Appunto, Ramipril + Amlodipin + Hydrochlorotiazid Adamed
  • Estonia · Ramdacordia Hct
  • Spain · Tarlodix Plus
  • Greece · Cardicin Plus, Rami-Amlo Plus
  • Croatia · Pinmirol Plus, Prylar H
  • Italy · Pressafix, Ramandiur
  • Portugal · Paniltri
  • Slovakia · Amirap Hct

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df1d31c7-6d53-4f14-b9a1-cca1fa528f83
GET /v1/drugs/df1d31c7-6d53-4f14-b9a1-cca1fa528f83?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "5 mg + 5 mg + 25 mg",
  "packaging": "05909991510787 ¦ Rp ¦ 149422\n100 kaps.\n05909991510794 ¦ Rp ¦ 149423\n30 kaps.\n05909991510800 ¦ Rp ¦ 149424\n10 kaps.\n05909991510817 ¦ Rp ¦ 149425\n60 kaps.\n05909991510824 ¦ Rp ¦ 149426\n28 kaps.",
  "substance": "Ramiprilum 5 mg + Amlodipini besilas 6.934 mg + Hydrochlorothiazidum 25 mg",
  "common_name": "Ramiprilum + Amlodipinum + Hydrochlorothiazidum",
  "pl_product_id": "100451456",
  "pozwolenie_nr": "27738",
  "auth_procedure": "DCP",
  "authorisation_validity": "2028-03-24"
}

See everything about ramipril, amlodipin und hydrochlorothiazid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.